Stock NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Navidea Biopharmaceuticals, Inc.

Equities

NAVB

US63937X2027

Delayed OTC Markets
Other stock markets
 11:45:48 2024-05-20 am EDT 		5-day change 1st Jan Change
0.03 USD +15.38% Intraday chart for Navidea Biopharmaceuticals, Inc. -14.29% -45.65%
2023 Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding CI
2023 Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NAVIDEA BIOPHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+15.38%-14.29%-45.65%-71.15%-97.92% 3M - - -
  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. Charts Navidea Biopharmaceuticals, Inc.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW